Smith+Nephew is proceeding with a revised executive remuneration framework after completing additional shareholder consultation triggered by significant opposition at its annual meeting.
The medical technology group said its board had resolved to implement the remuneration policy and Performance Share Plan approved at its May AGM, despite both resolutions receiving less than 80% shareholder support.
Under the UK Corporate Governance Code, that level of opposition required the company to undertake further engagement with shareholders and explain how it had responded.
Smith+Nephew said remuneration committee chair Sybella Stanley sought additional feedback from investors and proxy advisers following the vote. After that process, the board decided to proceed with the arrangements already approved by a majority of shareholders.
Chief executive Deepak Nath received a further Performance Share Plan award on 1 September equal to 350% of salary, taking his total 2026 performance-share opportunity to 650% of salary. He also received a Restricted Share Plan award equal to 25% of salary, taking the year’s restricted-share awards to 150% of salary.
The performance-share grant represented 323,728 shares based on a grant price of £12.744, assuming maximum vesting. A further 23,123 shares were awarded through the restricted plan.
The awards sit within a wider debate at Smith+Nephew over how a UK-listed global business should benchmark senior executive pay. In its remuneration materials, the company argued that leadership compensation needed to reflect the international medical technology market from which it recruits senior executives.
The board said Nath’s compensation had fallen well below the lower quartile of the peer group used for benchmarking and was around half its median level. It also pointed to improvements in operational and shareholder performance during his tenure when setting out the case for the new framework.
Before the AGM, Smith+Nephew consulted investors holding approximately 70% of its voting rights. The resulting policy was approved on 6 May, but the level of dissent meant the company had to return to shareholders after the vote.
The dispute reflects a persistent tension for multinational companies listed in London. Remuneration committees increasingly compare senior roles with international labour markets, particularly in sectors where executive talent is heavily concentrated in the US, while remaining accountable to UK investors and governance expectations.
That creates competing benchmarks. Paying materially below overseas peers can be presented as a recruitment and retention risk, while large increases in incentive opportunities can attract opposition where shareholders are unconvinced that potential rewards are proportionate to performance.
Shareholder votes on remuneration have consequently become a test of boards’ ability to explain the commercial case for pay structures. A policy can pass formally while still producing a level of opposition that requires further engagement and public reporting.
Smith+Nephew’s decision to proceed after consultation means attention now moves to how the incentives perform in practice. Performance-share awards remain contingent on future outcomes, while restricted shares vest over time subject to conditions set by the remuneration committee.
The scale of potential awards also increases scrutiny of the performance measures attached to them. Investors assessing executive packages increasingly look beyond headline percentages towards vesting conditions, relative performance, capital allocation, total shareholder returns, and whether management rewards remain aligned with the experience of long-term shareholders.
International pay comparisons are likely to remain contentious across the UK market. Several London-listed companies have argued that substantially higher US remuneration levels can make it harder to recruit globally, while governance bodies and investors continue to resist structures they regard as insufficiently linked to long-term value creation.
That debate is particularly acute where a company earns a large proportion of revenue internationally. Boards can argue that executive labour markets follow the business rather than the listing venue, while shareholders can still expect remuneration to reflect UK governance standards.
Smith+Nephew has said it will continue engaging shareholders and proxy advisers and will address feedback from the consultation in its 2026 annual report.
The board has therefore settled the immediate question by proceeding with the policy. The next assessment will come through performance, disclosure, and future shareholder votes as investors judge whether the enlarged opportunities produce outcomes proportionate to the rewards available.
You must be logged in to post a comment.